Key statistics
On Monday, Regenxbio Inc (RGNX:NSQ) closed at 9.24, 83.52% above the 52 week low of 5.04 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 8.71 |
|---|---|
| High | 9.65 |
| Low | 8.53 |
| Bid | 8.12 |
| Offer | 9.70 |
| Previous close | 9.04 |
| Average volume | 829.58k |
|---|---|
| Shares outstanding | 50.62m |
| Free float | 46.49m |
| P/E (TTM) | -- |
| Market cap | 467.76m USD |
| EPS (TTM) | -3.46 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- REGENXBIO, Inc. Stockholders Have Rights - Stockholders Who Lost Money Investing in RGNX Should Contact Robbins LLP for Information About Recovering Their Losses
- REGENXBIO to Participate in Upcoming Investor Conferences
- RGNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026
- RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
- REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX
- RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX
- Contact Levi & Korsinsky by April 14, 2026 Deadline to Join Class Action Against REGENXBIO Inc.(RGNX)
- REGENXBIO to Host Conference Call on March 5 to Discuss Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2026 in REGENXBIO Lawsuit - RGNX
More ▼
